US Pharma MarketingAs J&J separates from its orthopedics business, it lays off 56 in New Jersey
As J&J separates from its orthopedics business, it lays off 56 in New Jersey is a pharma and life sciences industry update from FiercePharma. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
In another round of Big Pharma layoffs in New Jersey, Johnson & Johnson is dismissing 56 employees at its corporate headquarters in New Brunswick. The layoffs are part of the company's effort to separate its orthopedics business.
Source: FiercePharma